Alkem Laboratories Ltd ALKEM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹5,250.00
- Day Range
- ₹5,259.00–5,259.00
- 52-Week Range
- ₹5,051.00–5,933.50
- Bid/Ask
- ₹5,250.00 / ₹5,259.00
- Shares Outstanding
- 119.57M
- Market Cap
- ₹627.72B
- Volume/Avg
- 11 / 146,378
Key Statistics
- Price/Earnings (Normalized)
- 29.02
- Price/Sales
- 4.16
- Dividend Yield (Trailing)
- 1.01%
- Dividend Yield (Forward)
- 0.38%
- Dividend Payment Schedule
- Mar, Sep
- Total Yield
- 1.01%
Company Profile
Alkem Laboratories Ltd is a diversified healthcare company engaged in the pharmaceutical business with operations. The Company is engaged in the development, manufacture, and sale of pharmaceutical products. It operates in one reportable business segment, Pharmaceuticals. Its operations include Domestic Pharma (Branded & Trade Generics, ActivLife and Alkem), Biotech (Biosimilars & Bio-CDMO), MedTech and Activa, and International Business. It focuses on chronic therapies, including anti-diabetes, dermatology, urology, and inhaled chronic respiratory. It caters to pharmaceutical firms, distributors, wholesalers, pharmacy chains, hospitals, and other healthcare-related institutional customers across domestic and international markets. It generates the maximum revenue from the United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 23,386
- Website
- https://www.alkemlabs.com
Valuation
|
Metric
|
ALKEM
|
|---|---|
Price/Earnings (Normalized) | 29.02 |
Price/Book Value | 4.55 |
Price/Sales | 4.16 |
Price/Cash Flow | 27.84 |
Price/Earnings
ALKEM
Financial Strength
|
Metric
|
ALKEM
|
|---|---|
Quick Ratio | 1.50 |
Current Ratio | 2.55 |
Interest Coverage | 17.17 |
Quick Ratio
ALKEM
Profitability
|
Metric
|
ALKEM
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ALKEM
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|?LpZ$M? | LOCK|WSb$ | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|%R>SDHk | LOCK|gg?@& | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|mW<?J$ | LOCK|$C | $41B | |||
| Zoetis Inc Class A
ZTS
| LOCK|&b>fFP@< | LOCK|C@ | $31B | |||
| Viatris Inc
VTRS
| LOCK|kl&$P>$ | LOCK|cX | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|W& | LOCK|y<? | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|wf^Y?jW | LOCK|<V | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|&?@N@s | LOCK|&> | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|@P$bfcj | LOCK|BH^b | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|>Jv@p>R | LOCK|RX | $2B |
United States